Low-Dose Everolimus Maintenance Therapy for Renal Angiomyolipoma Associated With Tuberous Sclerosis Complex
Objective: To assess the safety and efficacy of low-dose everolimus maintenance therapy for tuberous sclerosis complex-related renal angiomyolipoma (TSC-RAML) patients that had previously undergone standard-dose treatment for a minimum of 6 months.Materials and Methods: In total, 24 patients with a...
Guardado en:
Autores principales: | Cong Luo, Wen-Rui Ye, Xiong-Bin Zu, Min-Feng Chen, Lin Qi, Yang-Le Li, Yi Cai |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ab88bfc009544f3fbb563fa102839896 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Profile of everolimus in the treatment of tuberous sclerosis complex: an evidence-based review of its place in therapy
por: Capal JK, et al.
Publicado: (2016) -
Missed tuberous sclerosis complex with multi-system complications in a single patient
por: Shu Syi Lim, MBBS, et al.
Publicado: (2022) -
Use of microspheres in embolization for unruptured renal angiomyolipomas
por: Shimohira Masashi, et al.
Publicado: (2021) -
Tuberous Sclerosis: A Case Report with Oral Manifestation
por: Curi,Marcos Martins, et al.
Publicado: (2014) -
Dermoscopy of Facial Angiofibromas in Four Patients of Skin of Color with Tuberous Sclerosis Complex: A Case-Series
por: Rashmi Jindal, et al.
Publicado: (2021)